摘要
The timolol maleate 0.5% /dorzolamide 2% fixed combination (Cosopt) was commercially released in 1998 and is dosed twice daily. Boyle and associates and Clineschmidt and cowork-ers have demonstrated that Cosopt provided greater intraocular pressure control than timolol maleate 0.5% twice daily, or dorzolamide 2% three times daily, each given alone. Further,
出处
《国际眼科杂志》
CAS
2003年第1期120-120,共1页
International Eye Science
